Core Viewpoint - The company plans to hold its first extraordinary general meeting in 2026 to discuss two key proposals regarding its subsidiary, Hang'an Medical [1] Group 1: Capital Increase - The company intends to increase its investment in Hang'an Medical by 65 million yuan, with minority shareholders waiving their preemptive rights [1] - Following the capital increase, Hang'an Medical's registered capital will rise from 55 million yuan to 120 million yuan, and the company's ownership stake will increase from 90.91% to 95.83% [1] Group 2: Credit Guarantee - To support Hang'an Medical's operational and project investment needs, the company plans to provide a guarantee for a credit facility of up to 360 million yuan, with an authorization period of 12 months [1] - Hang'an Medical is currently in a growth phase and has obtained multiple medical device registration certificates [1]
安杰思:拟6500万元增资子公司并提供3.6亿元担保